tiprankstipranks
Trending News
More News >
Resmed (RMD)
NYSE:RMD
US Market

Resmed (RMD) Ratios

Compare
1,068 Followers

Resmed Ratios

RMD's free cash flow for Q2 2025 was $0.59. For the 2025 fiscal year, RMD's free cash flow was decreased by $ and operating cash flow was $0.32. See a summary of the company’s cash flow.
Ratios
TTM
Jun 24Jun 23Jun 22Jun 21
Liquidity Ratios
Current Ratio
2.59 3.12 2.80 1.73 2.53
Quick Ratio
1.69 1.81 1.72 1.23 1.84
Cash Ratio
0.26 0.30 0.40 0.32 0.77
Solvency Ratio
0.62 0.42 0.56 0.36 0.38
Operating Cash Flow Ratio
1.54 0.91 0.51 0.81 1.33
Short-Term Operating Cash Flow Coverage
39.83 21.79 11.05 61.39 66.93
Net Current Asset Value
$ 349.37M$ -253.97M$ 196.38M$ -267.69M$ -566.89M
Leverage Ratios
Debt-to-Assets Ratio
0.13 0.23 0.18 0.17 0.28
Debt-to-Equity Ratio
0.18 0.38 0.27 0.28 0.52
Debt-to-Capital Ratio
0.15 0.28 0.21 0.22 0.34
Long-Term Debt-to-Capital Ratio
0.13 0.26 0.19 0.18 0.32
Financial Leverage Ratio
1.41 1.63 1.52 1.64 1.84
Debt Service Coverage Ratio
15.94 14.58 18.41 19.17 16.79
Interest Coverage Ratio
28.88 23.89 44.83 37.67 20.05
Debt to Market Cap
0.03 0.05 0.03 0.02 0.04
Interest Debt Per Share
6.26 11.09 6.43 5.63 9.28
Net Debt to EBITDA
0.41 1.00 0.55 0.45 0.84
Profitability Margins
Gross Profit Margin
56.67%55.78%56.57%57.53%58.09%
EBIT Margin
27.97%27.52%27.47%28.54%27.36%
EBITDA Margin
32.73%32.18%32.88%34.38%33.49%
Operating Profit Margin
28.17%26.80%27.96%28.27%27.38%
Pretax Profit Margin
27.00%26.09%26.84%27.64%24.79%
Net Profit Margin
21.79%21.25%21.78%14.84%21.02%
Continuous Operations Profit Margin
21.79%21.25%21.78%14.84%21.02%
Net Income Per EBT
80.72%81.47%81.15%53.70%84.80%
EBT Per EBIT
95.83%97.33%96.02%97.79%90.54%
Return on Assets (ROA)
14.86%13.29%15.30%10.04%13.55%
Return on Equity (ROE)
20.99%21.73%23.19%16.44%24.90%
Return on Capital Employed (ROCE)
22.14%18.89%22.70%23.68%20.32%
Return on Invested Capital (ROIC)
17.69%15.25%18.20%12.60%17.09%
Return on Tangible Assets
28.80%26.17%27.70%19.71%27.64%
Earnings Yield
3.71%2.80%2.55%1.32%2.24%
Efficiency Ratios
Receivables Turnover
5.60 5.99 6.21 5.20 6.11
Payables Turnover
8.54 12.39 9.76 9.84 9.13
Inventory Turnover
2.47 1.87 2.09 2.97 2.97
Fixed Asset Turnover
6.70 6.34 5.68 5.40 5.52
Asset Turnover
0.68 0.63 0.70 0.68 0.64
Working Capital Turnover Ratio
3.07 2.96 3.76 4.04 3.92
Cash Conversion Cycle
170.33 226.54 196.09 155.90 142.56
Days of Sales Outstanding
65.23 60.93 58.75 70.14 59.75
Days of Inventory Outstanding
147.84 195.08 174.75 122.87 122.80
Days of Payables Outstanding
42.74 29.47 37.41 37.10 39.99
Operating Cycle
213.07 256.00 233.50 193.00 182.55
Cash Flow Ratios
Operating Cash Flow Per Share
9.53 4.72 2.40 5.07 5.56
Free Cash Flow Per Share
8.75 3.81 1.34 4.27 4.82
CapEx Per Share
0.78 0.91 1.07 0.80 0.73
Free Cash Flow to Operating Cash Flow
0.92 0.81 0.56 0.84 0.87
Dividend Paid and CapEx Coverage Ratio
3.53 1.77 0.87 2.14 2.42
Capital Expenditure Coverage Ratio
12.20 5.17 2.25 6.31 7.57
Operating Cash Flow Coverage Ratio
1.60 0.44 0.38 0.93 0.62
Operating Cash Flow to Sales Ratio
0.30 0.16 0.10 0.23 0.27
Free Cash Flow Yield
4.68%1.74%0.64%1.73%2.51%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
26.92 35.73 39.28 75.49 44.58
Price-to-Sales (P/S) Ratio
5.87 7.59 8.56 11.21 9.37
Price-to-Book (P/B) Ratio
5.65 7.76 9.11 12.41 11.10
Price-to-Free Cash Flow (P/FCF) Ratio
21.37 57.34 156.94 57.79 39.80
Price-to-Operating Cash Flow Ratio
19.61 46.25 87.20 48.62 34.54
Price-to-Earnings Growth (PEG) Ratio
2.01 2.45 0.62 -3.13 0.85
Price-to-Fair Value
5.65 7.76 9.11 12.41 11.10
Enterprise Value Multiple
18.34 24.60 26.57 33.04 28.82
EV to EBITDA
18.34 24.60 26.57 33.04 28.82
EV to Sales
6.00 7.91 8.74 11.36 9.65
EV to Free Cash Flow
21.86 59.75 160.24 58.59 41.00
EV to Operating Cash Flow
20.07 48.20 89.03 49.30 35.59
Tangible Book Value Per Share
10.45 5.50 7.38 3.89 1.10
Shareholders’ Equity Per Share
33.08 28.14 23.01 19.86 17.30
Tax and Other Ratios
Effective Tax Rate
0.19 0.19 0.19 0.46 0.15
Revenue Per Share
31.87 28.77 24.50 22.00 20.49
Net Income Per Share
6.94 6.12 5.34 3.27 4.31
Tax Burden
0.81 0.81 0.81 0.54 0.85
Interest Burden
0.97 0.95 0.98 0.97 0.91
Research & Development to Revenue
0.07 0.07 0.07 0.07 0.07
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.02 0.02 0.02 0.02 0.02
Income Quality
1.37 0.77 0.45 1.55 1.29
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis